CRISPR Therapeutics AG (NASDAQ: CRSP) Not A Good Play Anymore?
CRISPR Therapeutics AG (CRSP) concluded trading on Wednesday at a closing price of $44.43, with 5.69 million shares of worth about $252.87 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.48% during that period and on June 18, 2025 the price saw a […]
There Is Clear Momentum For CRISPR Therapeutics AG (NASDAQ: CRSP)
CRISPR Therapeutics AG (CRSP) concluded trading on Thursady at a closing price of $86.19, with 4.28 million shares of worth about $369.15 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 79.82% during that period and on Thursady the price saw a gain of […]
Better Times Ahead For CRISPR Therapeutics AG (NASDAQ: CRSP)?
CRISPR Therapeutics AG (CRSP) concluded trading on Wednesday at a closing price of $79.04, with 4.13 million shares of worth about $326.06 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 63.24% during that period and on Wednesday the price saw a gain of […]
Investors Should Take Note Of CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP) concluded trading on 01/11/24 at a closing price of $64.84, with 3.64 million shares of worth about $235.76 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 12.80% during that period and on Thursday the price saw a gain of […]
CRISPR Therapeutics AG (NASDAQ: CRSP) – Not A Clear Buying Opportunity?
Capital Research & Management Co has recently announced that it has increased stake in CRISPR Therapeutics AG (NASDAQ:CRSP) by 0.26%. After grabbing 6.09 million shares, the institutional investor is now in possession of 15789.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.66% having worth around $406.09 million. […]